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lymphocytes, cytoplasmic vacuolization and
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Abstract
Background: Despite significant research efforts on cancer therapy, diagnostics and imaging, many challenges
remain unsolved. There are many unknown details regarding the interaction of nanoparticles (NPs) and biological
systems. The structure and properties of gold nanoparticles (GNPs) make them useful for a wide array of biological
applications. However, for the application of GNPs in therapy and drug delivery, knowledge regarding their
bioaccumulation and associated local or systemic toxicity is necessary. Information on the biological fate of NPs,
including distribution, accumulation, metabolism, and organ specific toxicity is still minimal. Studies specifically
dealing with the toxicity of NPs are rare. The aim of the present study was to investigate the effects of
intraperitoneal administration of GNPs on histological alterations of the heart tissue of rats in an attempt to identify
and understand the toxicity and the potential role of GNPs as a therapeutic and diagnostic tool.
Methods: A total of 40 healthy male Wistar-Kyoto rats received 50 μl infusions of 10, 20 and 50 nm GNPs for 3 or 7 days.
Animals were randomly divided into groups: 6 GNP-treated rats groups and one control group (NG). Groups 1, 2 and 3
received infusions of 50 μlG N P so fs i z e1 0n m( 3o r7d a y s ) ,2 0n m( 3o r7d a y s )a n d5 0n m( 3o r7d a y s ) ,r e s p e c t i v e l y .
Results: In comparison with the respective control rats, exposure to GNPs doses produced heart muscle disarray
with a few scattered chronic inflammatory cells infiltrated by small lymphocytes, foci of hemorrhage with
extravasation of red blood cells, some scattered cytoplasmic vacuolization and congested and dilated blood
vessels. None of the above alterations were observed in the heart muscle of any member of the control group.
Conclusions: The alterations induced by intraperitoneal administration of GNPs were size-dependent, with smaller ones
inducing greater affects, and were also related to the time exposure to GNPs. These alterations may indicate scattered
cytoplasmic vacuolization, which may induce the toxicity effect through an inability to deal with the accumulated
residues resulting from metabolic and structural disturbances caused by these NPs. These histological alterations were
more prominent with 10 nm size particles than with the larger ones. The interaction of GNPs with proteins and various
cell types should be considered as part of the toxicological evaluation. Additional experiments related to plasma, tissues
cytokine, antioxidant defense mechanism, lipid peroxidation, histomorphologcal and ultrastructure will be performed to
identify and understand the toxicity and the potential use of GNPs as therapeutic and diagnostic tools.
Keywords: gold nanoparticles, size, heart muscle, histology, inflammatory, nanotoxicity, cytoplasmic vacuolization,
rats
Correspondence: abdelhalimmak@yahoo.com
Department of Physics and Astronomy, College of Science, King Saud
University, Saudi Arabia
Abdelhalim Lipids in Health and Disease 2011, 10:233
http://www.lipidworld.com/content/10/1/233
© 2011 Abdelhalim; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Introduction
Nanoparticles (NPs) are being investigated for gene
delivery purposes [1-3] and cancer therapy [4]. Data
concerning the behavior and toxicity of particles mainly
comes from studies on inhaled NPs [5].
NPs may differ in reactivity and solubility and may inter-
act with various endogenous proteins, lipids, polysacchar-
ides and cells. Based on experiences in inhalation
toxicology, a series of tests was proposed for evaluation of
the toxicity of nanoparticles used in drug delivery systems
[6]. GNPs can easily enter cells, and the demonstration
that amine and thiol groups bind strongly to GNPs has
enabled their surface modification with amino acids and
proteins for biomedical applications [7,8].
All NPs, upon exposure to tissues and fluids of the body,
will immediately adsorb some of the macromolecules that
they encounter at their portal of entry onto their surface.
The specific features of this adsorption process will
depend on the surface characteristics of the particles,
including surface chemistry and surface energy, and may
be modulated by intentional modification or functionaliza-
tion of the surfaces [9].
Gold, in its bulk form, has been considered an inert,
noble metal with therapeutic and medicinal value. Gold
nanoparticles (GNPs) are thought also to be relatively
non-cytotoxic [10], while the metallic nature of metal-
derived NPs and the presence of transition metals
encourages the production of reactive oxygen species
(ROS), leading to oxidative stress [11,12]. The use of nano-
particles as drug carriers may reduce the toxicity of the
incorporated drug (Kim et al 2003). There are differing
reports on the extent of the toxicity of these particles due
to the variety of GNP modifications, surface functional
attachments and shape and diameter size of the NPs
[13,14].
The particle size-dependent organ distribution of GNPs
has been studied in vivo [15-17]. In vivo studies in rats
exposed to aerosols of GNPs revealed that NPs were
rapidly taken into the system, with the highest accumula-
tion in the lungs, aorta, esophagus and olfactory bulb [18].
To understand and categorize the mechanisms behind
NP toxicity, information is needed on the response of liv-
ing systems to the presence of NPs of varying size, shape,
surface and bulk chemical composition. Very little infor-
mation on these aspects is presently available and this
implies that there is an urgent need for toxicokinetic data
for NPs.
The histological and histochemical characterization of
the heart tissues in the presence of GNPs has not been
documented. In the present study, we aimed to character-
ize the possible histological alterations in the heart tissues
after intraperitoneal administration of GNPs and, if altera-
tions do occur, to identify whether they are related to the
size of the GNPs and the time of exposure.
Materials and methods
A total of 40 healthy male Wistar-Kyoto rats were
obtained from the Laboratory Animal Center (College of
Pharmacy, King Saud University, Saudi Arabia). The rats
were nearly of uniform age (12 weeks) and weighed
220-240 g. Animals were randomly divided into groups,
3 GNP-treated rat groups and one control group (CG).
1 0 ,2 0a n d5 0n mG N P sw e r ea d m i n i s t e r e di n t r a p e r i t o -
nealy at a rate of 3 or 7 days as follows: Group 1
received an infusion of 50 μlG N P so fs i z e1 0n mf o r3
or 7 days (n = 10); Group 2 received an infusion of 50
μl GNPs of size 20 nm for 3 or 7 days (n = 10); Group
3 received an infusion of 50 μlG N P so fs i z e5 0n mf o r
3 or 7 days (n = 10). The control group received no
GNPs (n = 10).
The rats were maintained on standard laboratory rodent
diet pellets and housed in humidity and temperature-con-
trolled ventilated cages on a 12 h day/night cycle. All
experiments were conducted in accordance with the
guidelines approved by King Saud University Local Animal
Care and Use Committee.
Fresh portions of the heart from each rat were cut
rapidly, fixed in neutral buffered formalin (10%), then
dehydrated, with sequential exposure to grades of ethanol
(70, 80, 90, 95 and 100%). Dehydration was followed by
clearing the samples in 2 changes of xylene. Samples were
then impregnated with 2 changes of molten paraffin wax,
then embedded and blocked out. Paraffin sections (4-5
μm) were stained with haematoxylin and eosin (a conven-
tional histological stain) according to Pearse [19]. Bright-
field images were acquired using a Nikon Eclipse 800
microscope equipped with a Nikon DXM1200 color CCD
camera (Nikon Instruments Inc., Melville, NY).
Stained sections of control and GNPs-treated rats
were examined for alterations in the heart tissues.
Results and discussion
Size and morphology of different gold nanoparticles (GNPs)
The 10 and 20 nm GNPs had a spherical shape, while the
50 nm GNPs were hexagonal. The mean size of GNPs was
calculated from images taken by the transmission electron
microscope (TEM): The 10 nm GNPs had a mean size
9.45 ± 1.33 nm, 20 nm GNPs had a mean size 20.18 ±
1.80 and 50 nm GNPs had a mean size 50.73 ± 3.58
[20-23].
Histological alterations
No mortality occurred during the GNP administration
periods of 3 and 7 days in any of the experimental groups
of the present investigation, and no alterations were
observed in the appearance and behavior of GNP-treated
rats in comparison with the control group.
Control group (Figure 1): Microscopic pictures show
GNPs-normal rat demonstrating benign, blunt-looking
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with no pathological findings.
In comparison with the control group, the following
histological alterations were detected in the heart tissue
of GNP-treated rats. These histological alterations were
observed in Figures 2, 3, 4, 5, 6 and 7. The histological
alterations can be summarized as follows:
1) Extravasation of red blood cells, a few scattered,
lymphocytic infiltrated, normal-looking heart muscle
cells (Figures 2 and 5: GNPs-treated rat received 50 μl
of 10 nm particles for 3 days).
2) More dense hemorrhage and excess extravasation
of red blood cells (Figure 3: GNP-treated rat received 50
μl of 10 nm particles for 7 days).
3) Scattered extravasation of red blood cells, asso-
ciated with scattered to collected groups of lymphocytic
infiltrations (Figure 4: GNP-treated rat received 50 μlo f
20 nm particles for 3 days).
4) Extravasation of red blood cells with a few scattered
lymphocytic infiltrations (Figure 5: GNP-treated rat
received 50 μl of 20 nm particles for 7 days).
5) Scattered foci of hemorrhage with extravasation of
red blood cells; a few scattered cytoplasmic vacuoliza-
tion, which may indicate a toxic effect (Figure 6: GNP-
treated rat received 50 μl of 50 nm particles for 3 days).
6) Benign-looking heart muscle with benign fasci-
cles associated with congested dilated blood vessels
and extravasation of red blood cells (Figure 7: GNP-
treated rat received 50 μl of 50 nm particles for
7 days).
This infiltration was more prominent after 7 days of
administration and in rats receiving 10 and 20 nm
GNPs than in those receiving 50 nm GNPs. The appear-
ance of lymphocytic infiltration with extravasation of
red blood cells in the heart tissue may suggest that
GNPs interfere with the antioxidant defense mechanism,
leading to reactive oxygen species (ROS) generation
which, in turn, may imitate an inflammatory response.
Inflammatory cells infiltration was seen in the portal
triads and the perioral zones of GNP-treated rats. The
infiltrated cells were mainly lymphocytes and plasma
cells [20-23].
    
 
(40 x 8)            (100 x 2) 
Figure 1 GNP-normal rat demonstrating normal heart muscle.
     
  
(40 x 7)                          (40 x 3) 
Figure 2 GNP-treated rat that received 50 μl of 10 nm particles for 3 days demonstrating extravasation of red blood cells with a few
scattered lymphocytic infiltrations.
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lipid peroxidation [24,25] as well as decreased neutral
red retention time (NRRT) and the number of thiol-
containing proteins evident in electrophoretic separa-
tions. Cadmium may displace iron or copper from
metalloproteins, leading to oxidative stress via the Fen-
ton reaction [26].
It has been reported that 5 nm GNPs cause signifi-
cantly greater oxidative stress and cytotoxicity effects
than larger ones [27-29]. The 5 nm GNPs have been
shown to catalyze nitric oxide (NO) production from
endogenous S-nitroso adducts with thiol groups in
blood serum. NO reacts rapidly with superoxide-produ-
cing peroxynitrite (ONOO-), which can interact with
lipids, DNA, and proteins via direct oxidative reactions
or via indirect radical-mediated damage [28]. ROS pro-
duction could have resulted from the proportionately
high surface area of GNPs used in this investigation
[29,30].
There are several possible mechanisms of action for
the toxicity of particles, including injury of epithelial
tissue [30], inflammation, and oxidative stress response
[31,32]. At the cellular level, oxidative stress is consid-
ered to be of importance [33,34] and there are nanopar-
ticle-induced oxidative stress responses in keratinocytes,
macrophages and blood monocytes after in vitro expo-
sure [35,36].
NPs are nearly of the same dimensions as some bio-
logical molecules, such as proteins and nucleic acids.
Many of these biomolecules consist of long macromo-
lecular chains that are folded and shaped by coopera-
tive and weak interactions between side groups. The
GNPs may intrude into these complex folded
structures.
GNPs activate the phagocytic activity of the sinusoidal
cells by increasing the number of Kupffer cells to aid
removal of accumulated GNPs where lysosomes are
involved in the intracellular breakdown into small meta-
bolic products. The produced Kupffer cells hyperplasia
might be correlated with the amount of injury to the
hepatic tissue induced by GNP intoxication and repre-
sent a defense mechanism for detoxification. Kupffer
     
(40  x  3)       (40  x  4)   
 
                         (40 x 5) 
Figure 3 GNP-treated rat that received 50 μl of 10 nm particles for 7 days demonstrating more dense hemorrhage and excess
extravasation of red blood cells.
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(40 x 10) 
Figure 4 GNP-treated rat that received 50 μl of 20 nm particles for 3 days demonstrating scattered extravasation of red blood cells
associated with scattered to collected groups of lymphocytic infiltrations.
  
(40 x 5)                                             (40 x 6) 
 
 
(40 x 8) 
Figure 5 GNP-treated rat that received 50 μl of 20 nm particles for 7 days demonstrating extravasation of red blood cells with a few
scattered lymphocytic infiltrations.
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[37].
The scattered cytoplasmic vacuolization may indicate a
toxicity effect exhibited as a result of disturbances to
membrane function, which leads to massive influxes of
water and Na
+ due to GNP effects. Cellular swelling may
be accompanied by leakage of lysosomal hydrolytic
enzymes that lead to cytoplasmic degeneration and macro-
molecular crowding [38]. The vacuolated cytoplasm of the
hepatocytes of the GNPs treated rats might indicate acute
and subacute liver injury induced by these NPs. Variable
nuclei sizes were observed in some hepatocytes. This
change became apparent after 7 days of 50 nm GNPs
administration [20-23].
Fatty change was observed in some swelling hepato-
cytes of rats exposed to 100 μlo f1 0n mG N P sa n dt oa
lesser extent in those exposed to larger particles. This
hepatic liposis was more prominent in rats exposed to
GNPs for 7 days than those receiving the treatment for
3 days [20-23]. Hepatocyte fatty change may be due to
lipid peroxidation that leads to rough endoplasmic
damage and detachment of the cytoplasmic lipoprotein,
which indicate abnormal fat metabolism [22,25-27]. The
observed abnormal retention of lipids by hepatocytes
induced by GNPs may indicate toxic injury to the liver
in the form of hepatocyte liposis by these particles
[20-23].
The rats receiving 10 and 20 nm GNPs showed hemor-
rhage and excess extravasation of red blood cells. Less
disruption was observed in rats exposed to 50 nm GNPs,
while more damage was detected after 7 days than after 3
days of GNP exposure. This change may indicate heart
muscle damage and congestion by GNP exposure.
In agreement with bulk surface chemistry, metallic
NPs have considerable chemical reactivity, while ionic
crystal NPs have been observed to accumulate protein
layers when exposed to the cytoplasm or in the lympha-
tic fluid. This protein layer is possibly involved in the
interaction of the nanoparticle with the cellular system.
None of the above changes were observed in the heart
muscle of any member of the control group.
The interaction of NPs with living systems is also
affected by the characteristic dimensions. As noted
above, GNPs of smaller size may penetrate biomole-
cules, a situation not possible with larger GNPs. It has
been reported that inhaled NPs reach the blood and
may reach other target sites such as the liver, heart or
blood cells [39,40].
      
                     (A: 40 x 3)                                                   (B: 40 x 4)          
 
         
                     (C: 100 x 9)                                 (D: 100 x10) 
Figure 6 GNP-treated rat that received 50 μl of 50 nm particles for 3 days; A and B demonstrate scattered foci of hemorrhage with
extravasation red blood cells; C and D demonstrate a some scattered cytoplasmic vacuolization, which may indicate a toxicity effect.
Abdelhalim Lipids in Health and Disease 2011, 10:233
http://www.lipidworld.com/content/10/1/233
Page 6 of 9Reduction in size results in an enormous increase in
surface to volume ratio, so relatively larger numbers of
molecules are present on the surface, thus enhancing
intrinsic toxicity [41,42]. This may be one of the reasons
that smaller GNPs are generally more toxic than larger
particles with the same insoluble material when com-
pared on a mass dose basis.
With several different NPs (polyvinyl chloride, TiO2,
SiO2, Co, Ni), only Co induced toxicity in endothelial
cells, which was accompanied by the production of the
pro-inflammatory cytokine interleukin 8 (IL8) [43]. The
Cd, Ni and Pb concentrations significantly increased in
blood and all tissues of rats after the intraperitoneal
administration of 10, 20 and 50 nm GNPs compared
with the control, while different changes were observed
with the Co concentrations in blood and several tissues
of rats. Cobalt concentrations significantly increased
with 20 nm GNPs in blood and kidney tissue of rats
compared with the control, while it significantly
decreased in heart, lung and liver tissues of rats. 10, 20
and 50 nm GNPs may be an effective inducer of
oxidative stress in blood and all tissues of rats compared
with the control [44].
The present study demonstrates that the inflammation
produced in the heart tissue and other tissues/or organs
[20-23] was more prominent with smaller GNPs, which
induced greater affects, and was related to the time of
exposure to GNPs. It has been reported that smaller
GNPs cause significantly greater oxidative stress and
cytotoxicity effects than larger ones [25-27].
I nt h ep r e s e n ts t u d yw ed i dn o tm e a s u r et h eG N P
concentration in urine or feces but this aspect will be
taken into consideration in further experiments.
Conclusions
Histological alterations induced in heart tissue, as shown
in the results of the present work, could be an indica-
tion of congestion and disarray of heart muscle due to
GNP toxicity through an inability to deal with accumu-
lated residues resulting from metabolic and structural
disturbances caused by these particles. It was concluded
that these alterations are size-dependent, with smaller
    
 
          (100 x 7)           (40 x 6) 
 
 
                (100 x 8) 
Figure 7 GNP-treated rat that received 50 μl of 50 nm particles for 7 days demonstrating benign-looking heart muscle, with benign
fascicles associated with congested dilated blood vessels and extravasation of red blood cells.
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of exposure to GNPs.
In comparison with the respective control rats, exposure
to GNP doses produced heart muscle disarray, with a few
scattered chronic inflammatory cells infiltrated by small
lymphocytes, foci of hemorrhage with extravasation of red
blood cells, some scattered cytoplasmic vacuolization and
congested and dilated blood vessels. None of the above
alterations were observed in the heart muscle of any mem-
ber of the control group. The alterations induced by intra-
peritoneal administration of GNPs were size-dependent,
with smaller ones inducing greater affects, and were
related to the time of exposure to GNPs.
One mechanism of toxicity of NPs is likely to be induc-
tion of ROS and the consequent oxidative stress in cells
and organs. The appearance of a few chronic inflamma-
tory cells infiltrated by small lymphocytes, foci of hemor-
rhage with extravasation of red blood cells, some scattered
cytoplasmic vacuolization and congested and dilated blood
vessels may suggest that GNPs interact with proteins and
enzymes of the hepatic tissue, interfering with the antioxi-
dant defense mechanism and leading to ROS generation.
This, in turn, may induce stress in the hepatocytes, causing
them to undergo necrosis.
The interaction of GNPs with proteins and various
cell types should be considered as part of toxicological
evaluation. Additional experiments related to plasma,
tissues cytokine, antioxidant defense mechanism, lipid
peroxidation, histomorphologcal and ultrastructure will
be performed to identify and understand the toxicity
and the potential use of GNPs as therapeutic and diag-
nostic tools.
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